Malignant mesothelioma of the pericardium: case reports and immunohistochemical studies including Ki-67 expression

Hiroshi Hirano1, Tamaki Maeda, Motomu Tsuji

  • 1Department of Pathology, Toneyama National Hospital, Toyonaka, Japan. patho@toneyama.hosp.go.jp

Pathology International
|November 26, 2002
PubMed

Insights

Pericardial malignant mesothelioma (PMM) is a rare cancer. Autopsy cases reveal rapid progression and poor prognosis, likely due to heart function impairment.

Area of Science:

  • Oncology
  • Pathology

Background:

  • Pericardial malignant mesothelioma (PMM) is exceptionally rare, contrasting with more common pleural mesothelioma.
  • Understanding PMM's clinical and pathological characteristics is crucial due to its rarity.

Observation:

  • Three autopsy cases of PMM were analyzed for clinical and pathological features.
  • Macroscopic findings included thickened pericardium due to tumor invasion.
  • Microscopic examination confirmed epithelial-type malignant mesothelioma, with immunohistochemical results aligning with pleural mesothelioma.

Findings:

  • Ki-67 labeling index (LI) in PMM cases did not significantly differ from pleural mesothelioma cases.
  • All PMM cases exhibited rapid progression and mortality due to heart failure.

Implications:

  • The poor prognosis of PMM is attributed to tumor invasion restricting cardiac function, alongside tumor proliferation.
  • Further research into PMM pathogenesis and treatment strategies is warranted.

Related Concept Videos